Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin P Dinney

Showing results (181-190 of 202) with videos related to

Pageof 21
Sort By:
European Urology|September 22, 2009
Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohortHans-Martin Fritsche, Maximilian Burger, Robert S Svatek, et al.
BJU International|September 27, 2020
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinomaDavid D'Andrea, Surena Matin, Peter C Black, et al.
The Journal of Urology|August 27, 2021
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder CancerDavid D'Andrea, Peter C Black, Homayoun Zargar, et al.
European Urology|September 30, 2019
A Consensus Molecular Classification of Muscle-invasive Bladder CancerAurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al.
Circulation. Cardiovascular Genetics|May 6, 2014
Genome-wide association study identifies variants in casein kinase II (CSNK2A2) to be associated with leukocyte telomere length in a Punjabi Sikh diabetic cohortRicha Saxena, Andrew Bjonnes, Jennifer Prescott, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 7, 2008
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategyTadeusz Majewski, Sangkyou Lee, Joon Jeong, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder CancerSeth P Lerner, Dean F Bajorin, Colin P Dinney, et al.
The Journal of Urology|February 16, 2023
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional CohortPeter S Kirk, Yair Lotan, Homayoun Zargar, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 18, 2023
The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomyMatthew D Ho, Anna J Black, Homayoun Zargar, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Advancing Clinical Trial Design for Non-Muscle Invasive Bladder CancerElaine Chang, Noah M Hahn, Seth P Lerner, et al.
Pageof 21

Showing results (181-190 of 202) with videos related to

Sort By:
Pageof 21
European Urology|September 22, 2009
Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohortHans-Martin Fritsche, Maximilian Burger, Robert S Svatek, et al.
BJU International|September 27, 2020
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinomaDavid D'Andrea, Surena Matin, Peter C Black, et al.
The Journal of Urology|August 27, 2021
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder CancerDavid D'Andrea, Peter C Black, Homayoun Zargar, et al.
European Urology|September 30, 2019
A Consensus Molecular Classification of Muscle-invasive Bladder CancerAurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al.
Circulation. Cardiovascular Genetics|May 6, 2014
Genome-wide association study identifies variants in casein kinase II (CSNK2A2) to be associated with leukocyte telomere length in a Punjabi Sikh diabetic cohortRicha Saxena, Andrew Bjonnes, Jennifer Prescott, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 7, 2008
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategyTadeusz Majewski, Sangkyou Lee, Joon Jeong, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder CancerSeth P Lerner, Dean F Bajorin, Colin P Dinney, et al.
The Journal of Urology|February 16, 2023
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional CohortPeter S Kirk, Yair Lotan, Homayoun Zargar, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 18, 2023
The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomyMatthew D Ho, Anna J Black, Homayoun Zargar, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Advancing Clinical Trial Design for Non-Muscle Invasive Bladder CancerElaine Chang, Noah M Hahn, Seth P Lerner, et al.
Pageof 21